{"transactions":[{"id":732518,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:12:43.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":681,"derivative":{"exercise_price":499.86,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":681},"source":{"system":"sec-edgar","filing":"0001628280-26-044290","document":"wk-form4_1781813560.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044290/wk-form4_1781813560.xml","form_type":"4"}},{"id":732517,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:12:43.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":1371,"source":{"system":"sec-edgar","filing":"0001628280-26-044290","document":"wk-form4_1781813560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044290/wk-form4_1781813560.xml","form_type":"4"}},{"id":878273,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-28T00:13:57.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":57,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027."}],"balance_after":57,"derivative":{"exercise_price":319.44,"exercise_date":"2027-02-09","expiration_date":"2036-02-25","underlying":"Common Stock","underlying_shares":57},"source":{"system":"sec-edgar","filing":"0001000697-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000100069726000073/form4.xml","form_type":"4"}},{"id":878272,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-28T00:13:57.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":23,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027."}],"balance_after":1355,"source":{"system":"sec-edgar","filing":"0001000697-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000100069726000073/form4.xml","form_type":"4"}},{"id":953205,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T22:43:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"All of the shares of common stock underlying this stock option will vest and become exercisable on January 2, 2027."}],"balance_after":828,"derivative":{"exercise_price":381.96,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":828},"source":{"system":"sec-edgar","filing":"0001000697-26-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000100069726000023/form4.xml","form_type":"4"}},{"id":953204,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T22:43:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on January 2, 2027."}],"balance_after":1332,"source":{"system":"sec-edgar","filing":"0001000697-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000100069726000023/form4.xml","form_type":"4"}},{"id":1075100,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-05T23:23:22.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":1705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% of the shares on the first anniversary of the date of grant (August 1, 2026) and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":1705,"derivative":{"exercise_price":302.17,"expiration_date":"2035-08-01","underlying":"Common Stock","underlying_shares":1705},"source":{"system":"sec-edgar","filing":"0001628280-25-038008","document":"wk-form4_1754436199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025038008/wk-form4_1754436199.xml","form_type":"4"}},{"id":1075099,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T23:23:22.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which vest as to 50% of the shares on each of August 1, 2026 and August 1, 2027, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":967,"source":{"system":"sec-edgar","filing":"0001628280-25-038008","document":"wk-form4_1754436199.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025038008/wk-form4_1754436199.xml","form_type":"4"}},{"id":1262007,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":false,"shares":18533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":37067,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":18533},"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262006,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":false,"shares":16865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":16865},"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262005,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":false,"shares":9483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":37934,"derivative":{"exercise_price":40.12,"expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":9483},"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262004,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":false,"shares":15642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":31285,"derivative":{"exercise_price":27.09,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":15642},"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262003,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"sale","planned":true,"acquired":false,"shares":67333,"price":105.2398,"value":7086111.4534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.46, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":225808,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262002,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":true,"shares":9483,"price":40.12,"value":380457.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."}],"balance_after":293141,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262001,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":true,"shares":15642,"price":27.09,"value":423741.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."}],"balance_after":283658,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1262000,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":true,"shares":16865,"price":17.26,"value":291089.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."}],"balance_after":268016,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1261999,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-19","kind":"exercise","planned":true,"acquired":true,"shares":18533,"price":24.55,"value":454985.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."}],"balance_after":251151,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1261998,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":14630,"price":104.673,"value":1531365.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.37 to $105.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":232618,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1261997,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:45.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":2900,"price":104.0752,"value":301818.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.35 to $104.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":247248,"source":{"system":"sec-edgar","filing":"0001225208-25-001969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/doc4.xml","form_type":"4"}},{"id":1265132,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":false,"shares":4584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":4584},"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265131,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-16","kind":"exercise","planned":false,"acquired":false,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":4243,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":4243},"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265130,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":4362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":8725,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":4362},"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265129,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":23031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":23031,"derivative":{"exercise_price":106.14,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":23031},"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265128,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":8950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":8950,"derivative":{"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8950},"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265127,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2217,"price":106.11,"value":235245.87,"ownership":{"direct":true},"balance_after":250148,"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265126,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":true,"shares":4584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":252365,"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265125,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2052,"price":106.11,"value":217737.72,"ownership":{"direct":true},"balance_after":247781,"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265124,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-16","kind":"exercise","planned":false,"acquired":true,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":249833,"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265123,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2110,"price":106.11,"value":223892.1,"ownership":{"direct":true},"balance_after":245590,"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1265122,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-18T22:50:51.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":4362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":247700,"source":{"system":"sec-edgar","filing":"0001225208-25-001863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001863/doc4.xml","form_type":"4"}},{"id":1268451,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-14T22:28:44.000Z","date":"2025-02-12","kind":"exercise","planned":false,"acquired":false,"shares":3654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":10963,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":3654},"source":{"system":"sec-edgar","filing":"0001225208-25-001788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001788/doc4.xml","form_type":"4"}},{"id":1268450,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-14T22:28:44.000Z","date":"2025-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1767,"price":105.77,"value":186895.59,"ownership":{"direct":true},"balance_after":243338,"source":{"system":"sec-edgar","filing":"0001225208-25-001788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001788/doc4.xml","form_type":"4"}},{"id":1268449,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-14T22:28:44.000Z","date":"2025-02-12","kind":"exercise","planned":false,"acquired":true,"shares":3654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":245105,"source":{"system":"sec-edgar","filing":"0001225208-25-001788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001788/doc4.xml","form_type":"4"}},{"id":1270342,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T21:31:31.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":15087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":16.31,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":15087},"source":{"system":"sec-edgar","filing":"0001225208-25-001679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001679/doc4.xml","form_type":"4"}},{"id":1270341,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-13T21:31:31.000Z","date":"2025-02-12","kind":"sale","planned":true,"acquired":false,"shares":15087,"price":105.0663,"value":1585135.2681,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.778 to $105.28, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":241451,"source":{"system":"sec-edgar","filing":"0001225208-25-001679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001679/doc4.xml","form_type":"4"}},{"id":1270340,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-13T21:31:31.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":15087,"price":16.31,"value":246068.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."}],"balance_after":256538,"source":{"system":"sec-edgar","filing":"0001225208-25-001679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001679/doc4.xml","form_type":"4"}},{"id":1270339,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-13T21:31:31.000Z","date":"2025-02-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":16414,"price":105.98,"value":1739555.72,"ownership":{"direct":true},"balance_after":241451,"source":{"system":"sec-edgar","filing":"0001225208-25-001679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001679/doc4.xml","form_type":"4"}},{"id":1270338,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-02-13T21:31:31.000Z","date":"2025-02-11","kind":"grant","planned":true,"acquired":true,"shares":33944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2024 and subject to the completion of the concurrent three-year individual service period. On February 11, 2025, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."}],"balance_after":257865,"source":{"system":"sec-edgar","filing":"0001225208-25-001679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001679/doc4.xml","form_type":"4"}},{"id":1311792,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T17:53:31.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options vest in full on January 2, 2026."}],"balance_after":818,"derivative":{"exercise_price":368.26,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":818},"source":{"system":"sec-edgar","filing":"0001127602-25-000633","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000112760225000633/form4.xml","form_type":"4"}},{"id":1311791,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-06T17:53:31.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock which will vest in full on January 2, 2026."}],"balance_after":1025,"source":{"system":"sec-edgar","filing":"0001127602-25-000633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000112760225000633/form4.xml","form_type":"4"}},{"id":1317020,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Share Units","published_at":"2025-01-03T21:32:48.000Z","date":"2025-01-01","kind":"exercise","planned":true,"acquired":false,"shares":14901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance shares unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-12-31","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":14901},"source":{"system":"sec-edgar","filing":"0001225208-25-000201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000201/doc4.xml","form_type":"4"}},{"id":1317019,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-01-03T21:32:48.000Z","date":"2025-01-03","kind":"sale","planned":true,"acquired":false,"shares":9689,"price":89.8582,"value":870636.0998,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $89.52 to $90.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":223921,"source":{"system":"sec-edgar","filing":"0001225208-25-000201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000201/doc4.xml","form_type":"4"}},{"id":1317018,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-01-03T21:32:48.000Z","date":"2025-01-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":5212,"price":89.32,"value":465535.84,"ownership":{"direct":true},"balance_after":233610,"source":{"system":"sec-edgar","filing":"0001225208-25-000201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000201/doc4.xml","form_type":"4"}},{"id":1317017,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-01-03T21:32:48.000Z","date":"2025-01-01","kind":"exercise","planned":true,"acquired":true,"shares":14901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."}],"balance_after":238822,"source":{"system":"sec-edgar","filing":"0001225208-25-000201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000201/doc4.xml","form_type":"4"}},{"id":1504468,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":false,"shares":16863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":55600,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":16863},"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504467,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":false,"shares":15086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":15087,"derivative":{"exercise_price":16.31,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":15086},"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504466,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":false,"shares":16863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":16865,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":16863},"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504465,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":false,"shares":15642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":46927,"derivative":{"exercise_price":27.09,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":15642},"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504464,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-23","kind":"sale","planned":true,"acquired":false,"shares":47621,"price":75.1125,"value":3576932.3625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.86 to $75.48, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":223921,"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504463,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"sale","planned":true,"acquired":false,"shares":64454,"price":75.9118,"value":4892819.1572,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.512 to $76.22, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":271542,"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504462,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":true,"shares":15086,"price":16.31,"value":246052.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."}],"balance_after":335996,"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504461,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":true,"shares":15642,"price":27.09,"value":423741.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."}],"balance_after":320910,"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504460,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":true,"shares":16863,"price":17.26,"value":291055.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."}],"balance_after":305268,"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1504459,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-05-23T20:12:12.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":true,"shares":16863,"price":24.55,"value":413986.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024."}],"balance_after":288405,"source":{"system":"sec-edgar","filing":"0001225208-24-006325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006325/doc4.xml","form_type":"4"}},{"id":1635665,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":false,"shares":13662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":13.08,"expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":13662},"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635664,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Deferred Stock Units","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":false,"shares":3706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3706},"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635663,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-17","kind":"exercise","planned":false,"acquired":false,"shares":4583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":4584,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":4583},"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635662,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":8486,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":4243},"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635661,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":13662,"price":65.86,"value":899779.32,"ownership":{"direct":true},"balance_after":271542,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635660,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":13662,"price":13.08,"value":178698.96,"ownership":{"direct":true},"balance_after":285204,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635659,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1644,"price":65.82,"value":108208.08,"ownership":{"direct":true},"balance_after":271542,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635658,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."}],"balance_after":273186,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635657,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2033,"price":65.82,"value":133812.06,"ownership":{"direct":true},"balance_after":269480,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635656,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-17","kind":"exercise","planned":false,"acquired":true,"shares":4583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":271513,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635655,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1882,"price":65.82,"value":123873.24,"ownership":{"direct":true},"balance_after":266930,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1635654,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:40.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":268812,"source":{"system":"sec-edgar","filing":"0001225208-24-002571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002571/doc4.xml","form_type":"4"}},{"id":1639469,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:21:29.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":4362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":13087,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":4362},"source":{"system":"sec-edgar","filing":"0001225208-24-002300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002300/doc4.xml","form_type":"4"}},{"id":1639468,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-16T21:21:29.000Z","date":"2024-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1935,"price":65.95,"value":127613.25,"ownership":{"direct":true},"balance_after":264569,"source":{"system":"sec-edgar","filing":"0001225208-24-002300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002300/doc4.xml","form_type":"4"}},{"id":1639467,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-16T21:21:29.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":4362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":266504,"source":{"system":"sec-edgar","filing":"0001225208-24-002300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002300/doc4.xml","form_type":"4"}},{"id":1644199,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T21:18:59.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":38537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":38537,"derivative":{"exercise_price":64.99,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":38537},"source":{"system":"sec-edgar","filing":"0001225208-24-002036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002036/doc4.xml","form_type":"4"}},{"id":1644198,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-14T21:18:59.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":14617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":14617,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":14617},"source":{"system":"sec-edgar","filing":"0001225208-24-002036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002036/doc4.xml","form_type":"4"}},{"id":1654294,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-08T21:35:48.000Z","date":"2024-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":16262,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":262142,"source":{"system":"sec-edgar","filing":"0001225208-24-001776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824001776/doc4.xml","form_type":"4"}},{"id":1654293,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-02-08T21:35:48.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":36666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2023 and subject to the completion of the concurrent three-year individual service period. On February 6, 2024, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."}],"balance_after":278404,"source":{"system":"sec-edgar","filing":"0001225208-24-001776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824001776/doc4.xml","form_type":"4"}},{"id":1694185,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T16:14:09.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options fully vest on January 3, 2025"}],"balance_after":847,"derivative":{"exercise_price":328.62,"exercise_date":"2025-01-03","expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":847},"source":{"system":"sec-edgar","filing":"0001127602-24-000228","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000112760224000228/form4.xml","form_type":"4"}},{"id":1694184,"issuer":{"id":3080,"kind":"organization","name":"WATERS CORP /DE/"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-03T16:14:09.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grants of shares of common stock subject to restrictions that lapse January 3, 2025"}],"balance_after":706,"source":{"system":"sec-edgar","filing":"0001127602-24-000228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000697/000112760224000228/form4.xml","form_type":"4"}},{"id":1697159,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Share Units","published_at":"2024-01-03T01:30:12.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":23979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance shares unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":23979},"source":{"system":"sec-edgar","filing":"0001225208-24-000104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824000104/doc4.xml","form_type":"4"}},{"id":1697158,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-01-03T01:30:12.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8199,"price":57.81,"value":473984.19,"ownership":{"direct":true},"balance_after":241738,"source":{"system":"sec-edgar","filing":"0001225208-24-000104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824000104/doc4.xml","form_type":"4"}},{"id":1697157,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-01-03T01:30:12.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":23979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023."}],"balance_after":249937,"source":{"system":"sec-edgar","filing":"0001225208-24-000104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824000104/doc4.xml","form_type":"4"}},{"id":1981469,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":13661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."}],"balance_after":13662,"derivative":{"exercise_price":13.08,"expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":13661},"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981468,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":15086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":30173,"derivative":{"exercise_price":16.31,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":15086},"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981467,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":16863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":33728,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":16863},"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981466,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":30000,"price":46.6638,"value":1399914.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.575 to $46.74, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":225958,"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981465,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":75610,"price":46.6385,"value":3526336.985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.437 to $46.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":255958,"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981464,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":13661,"price":13.08,"value":178685.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":331568,"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981463,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":15086,"price":16.31,"value":246052.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":317907,"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":1981462,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-02T22:01:01.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":16863,"price":17.26,"value":291055.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":302821,"source":{"system":"sec-edgar","filing":"0001225208-23-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003166/doc4.xml","form_type":"4"}},{"id":2001472,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Deferred Stock Units","published_at":"2023-02-22T21:53:41.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":3661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":3661},"source":{"system":"sec-edgar","filing":"0001225208-23-002525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002525/doc4.xml","form_type":"4"}},{"id":2001471,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-22T21:53:41.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":1624,"price":46.23,"value":75077.52,"ownership":{"direct":true},"balance_after":285958,"source":{"system":"sec-edgar","filing":"0001225208-23-002525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002525/doc4.xml","form_type":"4"}},{"id":2001470,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-22T21:53:41.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":3661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":287582,"source":{"system":"sec-edgar","filing":"0001225208-23-002525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002525/doc4.xml","form_type":"4"}},{"id":2004881,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Deferred Stock Units","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-18","kind":"exercise","acquired":false,"shares":3706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":3706,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3706},"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004880,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":4583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":9167,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":4583},"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004879,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":12729,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":4243},"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004878,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-18","kind":"tax_withholding","acquired":false,"shares":1644,"price":46.54,"value":76511.76,"ownership":{"direct":true},"balance_after":283921,"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004877,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-18","kind":"exercise","acquired":true,"shares":3706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."}],"balance_after":285565,"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004876,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":2033,"price":46.54,"value":94615.82,"ownership":{"direct":true},"balance_after":281859,"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004875,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":4583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":283892,"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004874,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":1250,"price":46.48,"value":58100.0,"ownership":{"direct":true},"balance_after":279309,"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2004873,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-21T21:16:41.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":280559,"source":{"system":"sec-edgar","filing":"0001225208-23-002369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002369/doc4.xml","form_type":"4"}},{"id":2012124,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T00:15:47.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":7572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 28, 2014, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":7.39,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":7572},"source":{"system":"sec-edgar","filing":"0001225208-23-002148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002148/doc4.xml","form_type":"4"}},{"id":2012123,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":36910,"kind":"person","name":"Brennan Daniel J.","position":1,"cik":"0001595612","reported_name":"Brennan Daniel J.","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Deferred Stock Units","published_at":"2023-02-17T00:15:47.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":4153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":4153},"source":{"system":"sec-edgar","filing":"0001225208-23-002148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002148/doc4.xml","form_type":"4"}}],"next_cursor":"2023-02-17T00:15:47.000000Z,2012123"}